Flubrotizolam has become known as a novel benzodiazepine derivative. Synthesized for clinical purposes, flubrotizolam possesses remarkable hypnotic effects. Its pharmacological properties reveal a high affinity for the GABA receptor, resulting significant CNS suppression. Although its potential therapeutic applications, flubrotizolam's unregulated